Colombia Epidemiologic Surveillance Study

TerminatedOBSERVATIONAL
Enrollment

32,867

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

October 31, 2011

Conditions
PneumoniaMeningitisBacteremiaSepsis
Interventions
OTHER

Surveillance

No study drug, only interventions are blood draws and Chest X-rays

Trial Locations (3)

074065-050

Pfizer Investigational Site, Goiânia

Unknown

Pfizer Investigational Site, Bogotá

607-1159

Pfizer Investigational Site, Uruca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY